To Screen or Not to Screen?
Is childhood lipid disorder screening worthwhile? In the wake of updated guidelines, some argue that the benefits are worth the costs and risks – but others disagree
Michael Schubert |
Money is always a hot topic in healthcare – where it’s going, why it’s being spent, and how we can get more value out of each cent. Indeed, diseases are often referred to by their economic burdens, and it is by regulators’ weighting of cost benefit versus quality-of-life gains that therapeutics and diagnostic solutions are often assessed. Sometimes, not to intervene is deemed the favorable solution – and it is this strategy that has recently been suggested for the screening of lipid disorders in children.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine